Tác động của natri valproate lên chức năng thận của trẻ em mắc động kinh

Tseng CL, Wang PJ, Tsau YK, Lin MY, Shen YZ (1992) Urinary N-acetyl-beta-glucosaminidase (NAG) in children receiving antiepileptic drugs. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 33:251–256 Novo MLP, Izumi T, Yokota K, Fukuyama Y (1993) Urinary excretion of N-acetyl-β-glucosaminidase and β-galactosidase by patients with epilepsy. Brain Dev 15:157–160 Otsuka T, Sunaga Y, Hikima A (1994) UrinaryN-acetyl-β-glucosaminidase and guanidinoacetic acid levels in epileptic patients treated with anti-epileptic drugs. Brain Dev 16:437–440 Korinthenberg R, Wehrle L, Zimmerhackl LB (1994) Renal tubular dysfunction following treatment with antiepileptic drugs. Eur J Pediatr 153:855–858 Ryan SJ, Bishof NA, Baumann RJ (1996) Occurrence of renal fanconi syndrome in children on valproic acid therapy. J Epilepsy 9:35–38 Yuksel A, Cengiz M, Seven M, Cengiz S, Cenani A (1999) N-acetyl-beta-glucosaminidase and beta-galactosidase activity in children receiving antiepileptic drugs. Pediatr Neurol 20:24–26 Verrotti A, Greco R, Pascarella R, Matera V, Morgese G, Chiarelli F (2000) Renal tubular function in patients receiving anticonvulsant therapy: a long-term study. Epilepsia 41:1432–1435 Korinthenberg R, Säger J, Zimmerhackl LB (2000) Increased urinary excretion of tubular enzymes and proteins in children with epilepsy. Eur J Pediatr Neurol 4:263–267 Csáthy L, Oláh AV, Clemens B, György I, Varga J (2000) Urinary N-acetyl-β-d-glucosaminidase in epileptic children treated with antiepileptic drugs. Arch Dis Child 83:420–422 Altunbasak S, Yıldız D, Anarat A, Burgut HR (2001) Renal tubular dysfunction in epileptic children on valproic acid therapy. Pediatr Nephrol 16:256–259 Yoshikawa H, Yamazaki S, Watanabe T, Abe T (2003) Hypouricemia in severely disabled children: influence of valproic acid and bed-ridden state. Brain Dev 25:186–190 Attilakos A, Voudris KA, Garoufi A, Mastroyianni S, Dimou S, Prassouli A, Katsarou E (2006) Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study. Eur J Paediatr Neurol 10:237–240 Unay B, Akin R, Sarici SU, Gok F, Kurt I, Gokcay E (2006) Evaluation of renal tubular function in children taking anti-epileptic treatment. Nephrology 11:485–488 Mazaheri M, Samaie A, Semnani V (2011) Renal tubular dysfunction measured by N-acetyl-beta glucosaminidase/Creatinine activity index in children receiving antiepileptic drugs: a randomized controlled trial. Ital J Pediatr 37:21 Lenoir GR, Perignon JL, Gubler MC, Broyer M (1981) Valproic-acid—A possible cause of proximal tubular renal syndrome. J Pediatr 98:503–504 Hawkins E, Brewer E (1993) Renal toxcity induced by valproic acid (Depakene)—case 4. Pediatr Pathol 13:863–868 Lande MB, Kim MS, Bartlett C, Guaywoodford LM (1993) Reversible Fanconi syndrome-associated with valproate therapy. J Pediatr 123:320–322 Smith GC, Balfe JW, Kooh SW (1995) Anticonvulsants as a cause of Fanconi syndrome. Nephrol Dial Transplant 10:543–545 Fukuda Y, Watanabe H, Ohtomo Y, Yabuta K (1996) Immunologically mediated chronic tubulo-interstitial nephritis caused by valproate therapy. Nephron 72:328–329 Zaki EL, Springate JE (2002) Renal injury from valproic acid: case report and literature review. Pediatr Neurol 27:318–319 Yoshikawa H, Watanabe T, Abe T (2002) Fanconi syndrome caused by sodium valproate: report of three severely disabled children. Eur J Paediatr Neurol 6:165–167 Knorr M, Schaper J, Harjes M, Mayatepek E, Rosenbaum T (2004) Fanconi syndrome caused by antiepileptic therapy with valproic acid. Epilepsia 45:868–871 Watanabe T, Nakayasu K, Nagayama Y (2005) Autoimmune haemolytic anaemia and renal Fanconi syndrome caused by valproate therapy. Eur J Pediatr 164:186–187 Watanabe T, Yoshikawa H, Yamazaki S, Abe Y, Abe T (2005) Secondary renal Fanconi syndrome caused by valproate therapy. Pediatr Nephrol 20:814–817 Endo A, Fujita Y, Fuchigami T, Takahashi S, Mugishima H (2010) Fanconi syndrome caused by valproic acid. Pediatr Neurol 42:287–290 Inoue T, Tanaka Y, Otani R, Itabashi H, Murakami N, Nagai T, Sakuta R (2011) Three cases of Fanconi syndrome associated with valproate sodium treatment. No To Hattatsu 43:233–237 Shiari R, Bagherzade L, Alaei MR (2011) Fanconi syndrome associated with valporic acid: a case report. Iran Red Crescent Med J 13:844–845 Dhillon N, Hogler W (2011) Fractures and fanconi syndrome due to prolonged sodium valproate use. Neuropediatrics 42:119–121 Skalova S (2005) The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment. Acta Med (Hradec Kralove) 48:75–80 Sönmez F, Dönmez O, Önmez HM, Keskınoğlu A, Kabasakal C, Mır S (2002) Lead exposure and urinary N-acetyl β D glucosaminidase activity in adolescent workers in auto repair workshops. J Adolesc Health 30:213–216 Watanabe K, Kojima T, Fukuda Y, Ohbayashi K, Kobayashi T, Iwase S, Kobayashi Y (1987) Reliability of urinary N-acetyl-beta-D-glucosaminidase as an indicator or renal tubular damage in neonates. Biol Neonate 52:16–21 Norden AGW, Gardner SC, van’t Hoff W, Unwin RJ (2008) Lysosomal enzymuria is a feature of hereditary Fanconi syndrome and is related to elevated CI-mannose-6-P-receptor excretion. Nephrol Dial Transplant 23:2795–2803 Maesaka JK, Fishbane S (1998) Regulation of renal urate excretion: a critical review. Am J Kidney Dis 32:917–933 Fichsel G, Fichsel H, Liappis N (1993) Uric-acid serum concentration and antiepileptic treatment in childhood. Klin Padiatr 205:429–431 Mathew G, Knaus SJ (2006) Acquired Fanconi's syndrome associated with tenofovir therapy. J Gen Intern Med 21:C3–C5 Sebastian A, McSherry E, Morris RC Jr (1971) On the mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA). J Clin Invest 50:231–243 Cantani A, Mastrantoni F (1989) Hyperaminoaciduria: Toni-Fanconi and Lowe syndrome. Riv Eur Sci Med Farmacol 11:123–128 Lin CY, Chiang H (1988) Sodium-valproate-induced interstitial nephritis. Nephron 48:43–46 Finsterer J (2004) Mitochondriopathies. Eur J Neurol 11:163–186 Yoshikawa H, Yamazaki S, Abe T (2004) Hypouricemia in severely disabled children II: influence of elemental enteral nutrition on the serum uric acid levels. Brain Dev 26:43–46